跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
TEVA-BETAMETHASONE/ CALCIPOTRIOL - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
TEVA-BETAMETHASONE/ CALCIPOTRIOL
Authorized
STANDARD
TEVA-BETAMETHASONE/ CALCIPOTRIOL
teva canada limited
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
ad77aef8425e6c4f
Company
teva canada limited
Type
Standard
Approval Details
Approval Id
ad77aef8425e6c4f
Drug Approval Canada Name
TEVA-BETAMETHASONE/ CALCIPOTRIOL
Product Name
TEVA-BETAMETHASONE/ CALCIPOTRIOL
Status
Marketed
Status Date
2020-08-07
Original Market Date
2020-08-07
Din
02427419
Drug Class
Human
Dosage Form
Ointment
Route Of Administration
Topical
Schedule
Prescription
Ahfs
84:92.00
Atc Original
D07XC01 BETAMETHASONE
Atc Name
d 07 xc 01
Aig Number
0252270001
Company Name
teva canada limited
Company Address
30 Novopharm Court, Toronto, Ontario, Canada, M1B 2K9
Active Ingredients
CALCIPOTRIOL
50 MCG / G
BETAMETHASONE (BETAMETHASONE DIPROPIONATE)
0.5 MG / G
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
ad77aef8425e6c4f
Type
Standard
Back to Health Canada Approvals